Dyne Therapeutics Q4 EPS $(0.76) Beats $(0.79) Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings BeatsNews
Dyne Therapeutics (NASDAQ:DYN) reported quarterly losses of $(0.76) per share which beat the analyst consensus estimate of $(0.79) by 3.18 percent. This is a 13.64 percent increase over losses of $(0.88) per share from
Dyne Therapeutics (NASDAQ:DYN) reported quarterly losses of $(0.76) per share which beat the analyst consensus estimate of $(0.79) by 3.18 percent. This is a 13.64 percent increase over losses of $(0.88) per share from the same period last year.